Skip to main content
. 2015 Oct 5;6(38):41350–41359. doi: 10.18632/oncotarget.5534

Figure 2. Effect of CD4+CD25+proportion of T cells on overall survival with 95%CI among BC patients in stage ≤ II.

Figure 2